Autopsy report · NCT00830037
A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease
Cause of deathSafety
“Terminated by the DSMB based on low chance of finding differences in mGFR slopes, but higher risk of serious adverse events in the IV iron group (aIRR = 1.60)”
Life of this trial
- Registered 5 months after it had already started.
- 136 participants enrolled.
- Results were posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Indiana University
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Kidney Disease; Iron-deficiency Anemia
- Interventions
- IV Iron; Ferrous Sulfate
- Participants
- 136
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.